Stay updated on Baricitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Baricitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Baricitinib in Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov record for the baricitinib atopic dermatitis study is displayed instead of an error page, with study details, results-related measures, and participant information.SummaryDifference88%

- Check13 days agoChange DetectedThe ClinicalTrials.gov error page now displays revision v3.8.0 instead of v3.7.2. The study record remains inaccessible with a 403 Forbidden message.SummaryDifference0.2%

- Check20 days agoChange DetectedA sitewide banner announces NIH website transition updates and says NIH is adopting “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check27 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check34 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study content and navigation and effectively blocking access to the study details.SummaryDifference18%

Stay in the know with updates to Baricitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Baricitinib in Atopic Dermatitis Clinical Trial page.